Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements - Wikidata - awgldk - TriplyDB

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

http://www.wikidata.org/entity/Q26800693

about

Overview of IgG4-Related Tubulointerstitial Nephritis and Its Mimickers Epidemiology of Sjögren's Syndrome-from an Oral Perspective Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.Incidence and Mortality of Physician-Diagnosed Primary Sjögren Syndrome: Time Trends Over a 40-Year Period in a Population-Based US Cohort.A systematic review of primary Sjögren's syndrome in male and paediatric populations.Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.Hypokalemic Paralysis due to Primary Sjögren Syndrome: Case Report and Review of the Literature.The potential relationship between Flammer and Sjögren syndromes: the chime of dysfunction.Clinical Profile and Significance of Mucocutaneous Lesions of Primary Sjögren's Syndrome: A Large Cross-sectional Study with 874 Patients.Interstitial Pneumonia with Autoimmune Features: Overview of proposed criteria and recent cohort characterization.Systemic manifestations of primary Sjögren's syndrome in the NOD.B10Sn-H2b/J mouse model.Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.Orofacial Manifestations and Temporomandibular Disorders of Sjögren Syndrome: An Observational Study.Clinical characteristics and risk factors for overlapping rheumatoid arthritis and Sjögren's syndrome.Factors associated with severe dry eye in primary Sjögren's syndrome diagnosed patients.Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients: A case-control study.Lipschütz Genital Ulceration as Initial Manifestation of Primary Sjögren's Syndrome.Sjögren's syndrome: state of the art on clinical practice guidelines Whole-volume ADC Histogram and Texture Analyses of Parotid Glands as an Image Biomarker in Evaluating Disease Activity of Primary Sjögren's Syndrome

P2860

Q26775946-D246AF12-2F94-4E91-9BFE-E402AD6A8FE5 Q28069816-B9A82549-D8D3-4235-A618-CCC45E8E83D0 Q30234992-2FFED516-5622-497A-BD6B-F32BD45AF56C Q33667694-6558C696-D1CE-4BF5-8542-BA285B1AE10A Q37624932-C5D8639B-739C-4FBC-A0AF-481EBDFC3DF7 Q38401667-C12AB79B-EF4D-47DF-9299-41BC354A35D3 Q38666265-BFC01FF1-4C4B-4132-9A4D-E0BB300E64FD Q40067064-63488640-EE72-42EE-B4D1-5EFEA13E4B8B Q41395327-30D5A5F2-8A48-49EE-8484-D4B6CD8CA933 Q47098371-FF8E3F19-AFB5-4C45-B89F-58D20D4378C6 Q47106367-CEA3FCE8-A565-41B4-A109-E30ECB184807 Q47650949-E5CC25E8-1311-4E2F-A0A1-B9C3651B6E64 Q47758400-97EC5F1E-418D-4EEB-BDC2-A0B72FBE0884 Q48341665-58017996-2CA5-450B-97FF-E10C9E3F3053 Q53836187-2380EAA2-7EE2-47B5-9C16-67AE2FC5BCC2 Q55039221-48ACC67D-9E39-409B-A903-215F7C524169 Q55174890-23461E27-6439-4CAC-B640-FE3B64B80C5E Q55417704-46905C6A-8CB6-48DD-A245-447A5B90BEF0 Q55487593-A67CA72C-06D7-474E-9D12-BAF0BD56B7D9 Q58602888-FC3909F1-BEF9-47B7-B05E-2CAA2F4A3182 Q58603157-3272F9FB-0826-4FB8-BFAD-97D1296C83E0

P2860

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

http://www.wikidata.org/entity/Q26800693

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Characterization of systemic d ...... lmonary and renal involvements

@ast

Characterization of systemic d ...... lmonary and renal involvements

@en

Characterization of systemic d ...... lmonary and renal involvements

@nl

type

label

Characterization of systemic d ...... lmonary and renal involvements

@ast

Characterization of systemic d ...... lmonary and renal involvements

@en

Characterization of systemic d ...... lmonary and renal involvements

@nl

prefLabel

Characterization of systemic d ...... lmonary and renal involvements

@ast

Characterization of systemic d ...... lmonary and renal involvements

@en

Characterization of systemic d ...... lmonary and renal involvements

@nl

P1433

Q26800693-D17C9984-6E7E-4B12-AE59-2BBFA5F295DB

P1476

Q26800693-7CCE13E1-0135-4B4F-9507-9C10E5341B07

P2093

Q26800693-05B73CE5-7D48-4E29-978E-F3BE5FEE6FD0

Q26800693-0B04705E-A923-4711-8376-83FFD48C69E6

Q26800693-2579893D-A2A9-445B-AC64-942F99D7DF46

Q26800693-34D6FED8-DAD0-4DD6-8EF7-D9826D17705C

Q26800693-3CDD2651-322E-4642-B5EC-F3130C426890

Q26800693-3ED8D13F-225A-47FF-85D9-AA8E11E16708

Q26800693-6102B647-1631-4526-B209-CEE59B76206B

Q26800693-6583CFF2-89F0-430C-8D3A-F6C5E992BB0F

Q26800693-6B11AFFE-F038-4628-B164-76225EEB1E8B

Q26800693-74DC5280-2C19-44AA-A709-E7F9E135D92F

P2860

Q26800693-0D537D3A-D9A9-4DA1-AFC3-6CE4A731E761

Q26800693-1EF9808E-00A3-4F8E-A670-08A39125979F

Q26800693-25E1A941-F393-4D15-B76D-DFF06DACC88D

Q26800693-368C4C5D-D097-4187-A9F1-5C81C3CA2928

Q26800693-3BAFECD1-C6A8-48E6-9F2E-B614CA4EAC13

Q26800693-547A1F87-85F6-4676-ABF6-25F815CC3BC7

Q26800693-548145FA-6B02-437C-8CCC-FEB80F02CEBD

Q26800693-606B6FBD-6E00-4B53-914A-458FA4B5066C

Q26800693-60E29C86-FA68-4598-AF32-C6657896367F

Q26800693-711315B5-EE26-45F7-BF36-D82730CBA6D2

P304

Q26800693-58472957-BA9B-4D51-B472-4AFE11BB13CC

P31

Q26800693-6D3858A9-DF46-473D-85EE-0B1F87450A2A

P3181

Q26800693-DEC2466F-630B-4703-9AC6-43978AFC473F

P356

Q26800693-7328A825-20B3-44D6-B876-6E1BBD3BD418

P407

Q26800693-06208E8E-64F7-4B18-989D-579E5359DA0C

P433

Q26800693-AEC814F4-5FFA-4FBF-8880-176803577427

P478

Q26800693-5C1389C9-4AE8-425B-A5C7-C81224B6C221

P50

Q26800693-F55E12C5-A916-4ADB-9EF2-B976D38B16BD

P577

Q26800693-FEA54E09-DCA6-4955-BDBA-2FCC71CF4C2F

P698

Q26800693-ABE74A3B-0D8B-4445-89E3-AD9952090782

P932

Q26800693-1951BF4B-10AB-4AB5-81B5-9C1D00F05AA9

P3181

P356

P1433

P1476

Characterization of systemic d ...... lmonary and renal involvements

@en

P2093

Aike Kruize

http://www.w3.org/2001/XMLSchema#string

Athanasios Tzioufas

http://www.w3.org/2001/XMLSchema#string

Claudio Vitali

http://www.w3.org/2001/XMLSchema#string

EULAR Sjögren Syndrome Task Force

http://www.w3.org/2001/XMLSchema#string

Elke Theander

http://www.w3.org/2001/XMLSchema#string

Hendrika Bootsma

http://www.w3.org/2001/XMLSchema#string

Jacques-Eric Gottenberg

http://www.w3.org/2001/XMLSchema#string

Manuel Ramos-Casals

http://www.w3.org/2001/XMLSchema#string

Pilar Brito-Zerón

http://www.w3.org/2001/XMLSchema#string

Salvatore De Vita

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria

IgG4-related disease

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias

The overlap of Sjögren's syndrome with other systemic autoimmune diseases.

Clinical manifestations and early diagnosis of Sjögren syndrome.

Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases

Primary Sjögren's syndrome: new clinical and therapeutic concepts

The value of using the entire New York Heart Association's classification of heart and vascular disease.

Renal involvement in primary Sjögren's syndrome: a clinicopathologic study.

P304

2230-2238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3687847

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/RHEUMATOLOGY/KEV200

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26231345

http://www.w3.org/2001/XMLSchema#string

P932

6281074

http://www.w3.org/2001/XMLSchema#string